# Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM

> **NCT00274612** · PHASE4 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 801 (—)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Telmisartan
- **DRUG:** Ramipril

## Key facts

- **NCT ID:** NCT00274612
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-10
- **Primary completion:** 2003-11
- **Final completion:** 2003-11
- **Target enrollment:** 801 (—)
- **Last updated:** 2013-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00274612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00274612, "Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00274612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*